Rachel L Sagar, 1,2 Eva Åström, 3,4 Lyn S Chitty, 5,6 Belinda Crowe, 7 Anna L David, 1,2 Catherine DeVile, 7 Annabelle Forsmark, 8 Vera Franzen, 9 Göran Hermeren, 10 Melissa Hill , 5,6 Mats Johansson, 10 Caroline Lindemans, 11 Peter Lindgren, 12,13 Wouter Nijhuis, 14 Dick Oepkes, 15 Mirko Rehberg, 16 Nils-Eric Sahlin, 10 Ralph Sakkers, 14 O Semler, 16 Mikael Sundin, 13,17 Lilian Walther-Jallow, 13 E J T Joanne Verweij, 15 Magnus Westgren, 13 Cecilia Götherström 13 To cite: Sagar RL,ÅströmE,Chitty LS等。一项探索性开放标签多中心I/II期试验评估了产后或产前或产后和产后给药的安全性和疗效,同种异体扩展的胎儿间充质干细胞用于治疗婴儿和胎儿中严重肌动症的严重成骨的不完美症:BoostB4试验方案。BMJ Open 2024; 14:E079767。doi:10.1136/ bmjopen-2023-079767 div>
Rachel L Sagar, 1,2 Eva Åström, 3,4 Lyn S Chitty, 5,6 Belinda Crowe, 7 Anna L David, 1,2 Catherine DeVile, 7 Annabelle Forsmark, 8 Vera Franzen, 9 Göran Hermeren, 10 Melissa Hill , 5,6 Mats Johansson, 10 Caroline Lindemans, 11 Peter Lindgren, 12,13 Wouter Nijhuis, 14 Dick Oepkes, 15 Mirko Rehberg, 16 Nils-Eric Sahlin, 10 Ralph Sakkers, 14 O Semler, 16 Mikael Sundin, 13,17 Lilian Walther-Jallow, 13 E J T Joanne Verweij, 15 Magnus Westgren, 13 Cecilia Götherström 13 To cite: Sagar RL,ÅströmE,Chitty LS等。一项探索性开放标签多中心I/II期试验评估了产后或产前或产后和产后给药的安全性和疗效,同种异体扩展的胎儿间充质干细胞用于治疗婴儿和胎儿中严重肌动症的严重成骨的不完美症:BoostB4试验方案。BMJ Open 2024; 14:E079767。doi:10.1136/ bmjopen-2023-079767 div>